Literature DB >> 20213049

The location of endogenous wild-type p53 protein in 293T and HEK293 cells expressing low-risk HPV-6E6 fusion protein with GFP.

Lina Sun1, Xinxin Shen, Yan Liu, Ge Zhang, Jianchun Wei, Huijuan Zhang, Enming Zhang, Fengqin Ma.   

Abstract

The mechanism underlining human papillomaviruses (HPVs) causing cancer has been studied extensively, and it was concluded that the high-risk HPVs' E6 targeted and degraded tumor suppressor protein p53, leading to infected cells malignant transformation. In contrast, the low-risk HPVs only cause proliferative but non-invasive lesions of infected epithelia. Therefore, we hypothesized that low-risk HPVs' E6 might interact with p53 in a different pattern. We used a mammalian green fluorescent protein (GFP) expression system to express HPV-18E6 and HPV-6E6 fusion proteins in wild-type (wt) p53 cell lines, 293T and HEK293 cells, to investigate the traffic and location of E6s and p53. The results indicated GFP-18E6 was mainly expressed in nucleus, whereas GFP-6E6 was expressed exclusively in cytoplasm. Endogenous wt p53 was shown to be localized in the nuclei of cells transfected with GFP- 18E6. Interestingly, for the first time, we observed that p53 was trapped in the cytoplasm and never translocated into the cell nuclei transfected with GFP-6E6. In conclusion, HPV-6E6 was responsible for the cytoplasmic localization of p53. Therefore, our experiments provide a new insight into the pathogenesis of HPV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213049     DOI: 10.1093/abbs/gmq009

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  8 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.

Authors:  Yan-Ning Rui; Zhen Xu; Zhihua Chen; Sheng Zhang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

4.  The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14.

Authors:  Ningning Zhao; An-Sheng Zhang; Aaron M Wortham; Shall Jue; Mitchell D Knutson; Caroline A Enns
Journal:  Nutrients       Date:  2017-12-08       Impact factor: 5.717

5.  The Effect of Bacterial Peptide p28 on Viability and Apoptosis Status of P53-null HeLa Cells.

Authors:  Haniyeh Abuei; Abbas Behzad-Behbahani; Fatemeh Faghihi; Ali Farhadi; Gholam Reza Rafiei Dehbidi; Mohammad Pirouzfar; Farahnaz Zare
Journal:  Adv Pharm Bull       Date:  2019-10-24

6.  Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway.

Authors:  Haibiao Xie; Kaifang Ma; Kenan Zhang; Jingcheng Zhou; Lei Li; Wuping Yang; Yanqing Gong; Lin Cai; Kan Gong
Journal:  Cell Death Dis       Date:  2021-01-05       Impact factor: 8.469

7.  The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells.

Authors:  Yinghui Wang; Yihang Xie; Boxuan Sun; Yuwei Guo; Ling Song; Dawit Eman Mohammednur; Chunyan Zhao
Journal:  Infect Agent Cancer       Date:  2021-12-24       Impact factor: 2.965

8.  Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.

Authors:  Chandrima Gain; Samaresh Malik; Shaoni Bhattacharjee; Arijit Ghosh; Erle S Robertson; Benu Brata Das; Abhik Saha
Journal:  PLoS Pathog       Date:  2020-02-24       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.